agp millie;

Dr. Tester's application for grant to study agp pain tolerance.

Test plan: Pain application via hypodermic injection of proprietary rapid-metabolizing serum in the nipple, areola, deep breast tissue, clitoris, labia majora, labia minora and anal rim. Benefits of rapid-metabolization include quick subject recovery that allows many more tests per day than standard pain studies. Serum produces localized violent sensations similar to open flame exposure. No tissue damage or desensitization occurs, and the agp will be "ready" for the next pain application in only 15 to 20 minutes, even if the strength and location of the injection produced so much pain as to cause unconciousness (a common occurance when a direct clitoral injection of a 10% solution or greater is used). Subject to be fully restrained in gynecological stirrups with additional knee and arm restraints to enhance pudendum accessibility and breast prominence, respectively.

Please reply in these pages.

Yours;
Dr. Tester